A Syx-RhoA-Dia1 signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in glioblastoma
Preprint
Abstract
Glioblastomas (GBM) are aggressive tumors that lack effective treatments. Here, we show that the Rho family guanine nucleotide exchange factor Syx promotes GBM cell growth both in vitro and in orthotopic GBM patient-derived xenografts. Growth defects upon Syx depletion are attributed to prolonged mitosis, increased DNA damage, G2/M cell cycle arrest, and cell apoptosis, mediated by altered mRNA and protein expression of various cell cycle regulators. These effects are phenocopied by depletion of the Rho downstream effector Dia1 and are due at least in part to increased cytoplasmic retention and reduced activity of the YAP/TAZ transcriptional coactivators. Further, targeting Syx signaling cooperates with radiation treatment and temozolomide (TMZ) to decrease viability in GBM cells irrespective of their inherent response to TMZ. Taken together, the data indicate that a Syx-RhoA-Dia1-YAP/TAZ signaling axis regulates cell cycle progression, DNA damage, and therapy resistance in GBM and argue for its targeting for cancer treatment. One Sentence Summary: Syx promotes growth and therapy resistance in glioblastoma.Keywords
All Related Versions
- Published version: JCI Insight, 8 (13).
This publication has 56 references indexed in Scilit:
- Fatal correlation between YAP1 expression and glioma aggressiveness: clinical and molecular evidenceThe Journal of Pathology, 2018
- TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phaseBiochemical and Biophysical Research Communications, 2017
- A Mechanical Checkpoint Controls Multicellular Growth through YAP/TAZ Regulation by Actin-Processing FactorsCell, 2013
- ATM inhibitor KU-55933 increases the TMZ responsiveness of only inherently TMZ sensitive GBM cellsJournal of Neuro-Oncology, 2012
- Establishment, Maintenance, and In Vitro and In Vivo Applications of Primary Human Glioblastoma Multiforme (GBM) Xenograft Models for Translational Biology Studies and Drug DiscoveryCurrent Protocols in Pharmacology, 2011
- Demonstration of anti-tumor activity of oncolytic measles virus strains in a malignant pleural effusion breast cancer modelBreast Cancer Research and Treatment, 2009
- A Cell Active Chemical GEF Inhibitor Selectively Targets the Trio/RhoG/Rac1 Signaling PathwayChemistry & Biology, 2009
- Elucidation of a Universal Size-Control Mechanism in Drosophila and MammalsCell, 2007
- Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensationChromosoma, 1997
- Dichotomy of astrocytoma migration and proliferationInternational Journal of Cancer, 1996